Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1)

BACKGROUND: Treatment decisions in prostate cancer (PCa) rely on disease stratification between localised and metastatic stages, but current imaging staging technologies are not sensitive to micro-metastatic disease. Circulating tumour cells (CTCs) status is a promising tool in this regard. The Pars...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hammouri, Tarek, Almeida-Magana, Ricardo, Lawrence, Rachel, Duffy, Tom, White, Laura, Burke, Edwina, Kudahetti, Sakunthala, Collins, Justin, Rajan, Prabhakar, Berney, Daniel, Gabe, Rhian, Shaw, Greg, Lu, Yong-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288675/
https://www.ncbi.nlm.nih.gov/pubmed/37353740
http://dx.doi.org/10.1186/s12885-023-11081-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288675/
https://www.ncbi.nlm.nih.gov/pubmed/37353740
http://dx.doi.org/10.1186/s12885-023-11081-0

Ejemplares similares